Skip to content
Medical Health Aged Care

Memory Walk & Jog is coming back to Redcliffe!

Dementia Australia 2 mins read

Dementia Australia’s biggest annual fundraiser returns to Redcliffe to raise much-needed funds to support people living with dementia, their families and carers.

 

On Saturday 6 June 2026, walkers, runners and joggers will set off from Scarborough Beach Park, Redcliffe to raise money, boost awareness and to get active for brain health.  

 

Dementia Australia CEO Tanya Buchanan said the Redcliffe 2026 Memory Walk & Jog is more important than ever with dementia now the leading cause of death for Australians.[1]

 

“Memory Walk & Jog is more than a fundraiser,” Professor Buchanan said.

 

“In 2025, an estimated 433,300 Australians are living with dementia, including more than 8,060 in the Moreton Bay region.

 

“Without a significant intervention, the number of Australians living with dementia is expected to exceed one million by 2065.[2]

 

“Each Memory Walk & Jog event helps raise awareness and funds, but also encourages people to get active and socially connect – two simple, evidence-based things we can all do to help reduce our risk of developing dementia.”  

 

This year, Dementia Australia aims to break participation records for Memory Walk & Jog and raise more than $2.5 million to help fund essential support, education and services for people living with dementia, their families and carers.  

 

Anyone can get involved, whether it is through running, walking, volunteering or donating to a participant you would like to support.

 

Registrations are open now for the 2026 Memory Walk & Jog event in Redcliffe and across Australia. More details can be found at www.memorywalk.com.au/event/redcliffe

 

 

-Ends-

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 433,000 Australians living with dementia, and the more than 1.7 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

Media contacts: Teresa Cong, Senior Media & Communications Advisor  0423 383 564  [email protected]

Molly Bryan, Senior Media & Communications Advisor 02 8875 4624 [email protected]

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

Photos and video of previous Memory Walk & Jog events for publication are available for use.

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.



[1]  Australian Institute of Health and Welfare (AIHW) (2025) Dementia in Australia report, AIHW, Australian Government

 

[2] Australian Institute of Health and Welfare (AIHW) (2025) Dementia in Australia report, AIHW, Australian Government

 

Media

More from this category

  • Medical Health Aged Care
  • 12/11/2025
  • 07:00
RMIT University

Blood test offers hope for more effective ovarian cancer treatment

New clinical research has identified a blood test that can reveal which women are more likely to respond to particular treatment for ovarian cancer,…

  • Contains:
  • Medical Health Aged Care
  • 11/11/2025
  • 16:00
Uniting NSW.ACT

Results of Australia’s first injectable opioid treatment trial announced at 2025 APSAD conference

Media Release 11th November 2025 The results of Australia’s first injectable opioid treatment trial were revealed at the 2025 APSAD (The Australasian Professional Society on Alcohol and other Drugs) conference in Sydney today. Two presentations today outlined the initial findings of the trial – one by Dr Jake Rance, Centre for Social Research in Health at UNSW on ‘The ‘acceptability’ of supervised injectable opioid treatment: Staff and participant reflections from the Australian ‘Feasibility of Injectable Opioid Treatment’ (FOpIT) and the other by Dr Craig Rodgers on the initial outcomes of recruitment, retention and safety. The study is a partnership between…

  • Medical Health Aged Care
  • 11/11/2025
  • 12:26
Samsung Epis Holdings Co., Ltd.

Samsung Epis Holdings Announces Establishment of Epis NexLab, a New Subsidiary to Advance Next-Generation Biotechnology Platforms

INCHEON, Korea–BUSINESS WIRE– Samsung Epis Holdings Co., Ltd. today announced the establishment of Epis NexLab Co., Ltd., a new subsidiary that will focus on…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.